Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05560399
Title A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma (CC-220)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Icahn School of Medicine at Mount Sinai
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.